>

Guardant Health Profile

<div class='circular--portrait' style='background:#FF0F00;color: white;font-size:4em;padding-top: 25px;;'>GU</div>

Performance

Odds of Distress

Analyze Filter   Earning Report: February 24, 2020
Equity ratings for Guardant Health are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 20, 2019 and ending today February 18, 2020. Click here to learn more.

Guardant Health Profile

Upcoming quarterly earning report is expected on February 24, 2020. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 454 people. more on Guardant Health
Guardant Health Fama & French Healthcare
Healthcare
Fama & French Classification
Guardant Health SEC Filings
Guardant Health SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameGuardant Health
CEO, DirectorHelmy EltoukhyView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Guardant Health
Piotroski F Score
Academic score to determine the current strength of Guardant Health financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Guardant Health ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Guardant Health representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
EBITDA Margin
Gross Margin
Profit Margin
Guardant Health (GH) is traded on BATS Exchange in USA. It is located in 505 Penobscot Drive and employs 454 people. Guardant Health is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with market capitalization of 6.23 B. Guardant Health is active under Healthcare sector as part of Diagnostics & Research industry. The entity has 92.97 M outstanding shares of which 3.06 M shares are currently sold short in the market by investors with about 3.88 days to cover all shorted shares. The company reports about 545.63 M in cash with (66.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.87.
Check Guardant Health Probability Of Bankruptcy

Ownership Allocation (%)

Guardant Health Target Price Odds Analysis

Odds Below 85.72HorizonTargetOdds Above 85.72
97.30%30 days 85.72 2.66%
Based on normal probability distribution, the odds of Guardant Health to move above current price in 30 days from now is roughly 2.66 (This Guardant Health probability density function shows the probability of Guardant Health Stock to fall within a particular range of prices over 30 days) .

Guardant Health Top Holders

Guardant Health Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Revenues    

Guardant Health Against Markets

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Guardant Health Upcoming and Recent Events

Guardant Health Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 24, 2020
Next Earnings ReportMay 14, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 24, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Guardant Health Corporate Filings

Guardant Health SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Regulation FD Disclosure
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Other Events

Guardant Health Corporate Directors

Dipchand Nishar Independent Director
Ian Clark Lead Independent Director
Bahija Jallal Director
Please check Risk vs Return Analysis. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Company logos by clearbit